52
Participants
Start Date
April 30, 2012
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
LY2979165
Capsules administered orally
LY2140023
Tablets administered orally
Placebo
Administered orally
Ketamine
Administered intravenously (IV)
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London
Eli Lilly and Company
INDUSTRY